← Scroll for more →
Achieve Life Sciences, Inc. (ACHV)
In Vitro & In Vivo Diagnostic Substances
Latest Price
$7.19
TTM P/E
--
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
0.20
P/B Ratio
35.95
Institutional Ownership
82.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 7.61M | $49.0M | 7.41% | -- | 2026-06-30 |
| Tpg GP A, LLC | 6.88M | $44.0M | 6.70% | -- | 2026-06-30 |
| venBio Partners LLC | 5.91M | $38.0M | 5.76% | -- | 2026-06-30 |
| Logos Global Management LP | 5.42M | $35.0M | 5.28% | -- | 2026-06-30 |
| BlackRock, Inc. | 5.27M | $34.0M | 5.13% | +4.83M | 2026-06-30 |
| Franklin Resources Inc | 4.95M | $32.0M | 4.82% | +584.0K | 2026-06-30 |
| Paradigm Biocapital Advisors LP | 4.95M | $32.0M | 4.82% | -- | 2026-06-30 |
| Vanguard Capital Management LLC | 4.14M | $27.0M | 4.03% | +1.94M | 2026-06-30 |
| Propel Bio Management, LLC | 4.03M | $26.0M | 3.93% | +247.6K | 2026-06-30 |
| Marshall Wace, LLP | 3.77M | $24.0M | 3.67% | +2.75M | 2026-06-30 |